This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bouchie, A. SGLT2 inhibitors enter crowded diabetes space. Nat Biotechnol 31, 469–470 (2013). https://doi.org/10.1038/nbt0613-469
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt0613-469
This article is cited by
-
Genomics pioneer gets its first drug
Nature Biotechnology (2017)
-
Real world points to SGLT-2 blockers advantage
Nature Biotechnology (2017)
-
BMS sells diabetes business
Nature Biotechnology (2014)